Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study.
Gamma-aminobutyric acid receptor type A (GABA(A)) receptor channels mediate fast inhibitory neurotransmission throughout the central nervous system while the expression of ionotropic glycine receptors is mainly restricted to the spinal cord and brain stem. Neuroactive steroids are well known as positive allosteric modulators of GABA(A) receptor function. Furthermore, there have been hints for an interaction of neuroactive steroids with ionotropic glycine receptors. The aim of the study was to characterize the effect of androsterone and progesterone on alpha(1) and alpha(1)beta glycine receptor and alpha(1)beta(2)gamma(2) GABA(A) receptor channels and to examine the molecular interactions between ligands and receptors. Electrophysiological recordings were performed on HEK 293 cells using the patch clamp technique in combination with an ultrafast perfusion system. A direct activation of inhibitory ionotropic receptors was observed for androsterone at GABA(A) receptor channels. A coactivation of currents elicited by nonsaturating agonist concentrations was observed with androsterone and progesterone at glycine and GABA(A) receptor channels. We could show that association of beta subunits with alpha subunits affects the sensitivity of glycine receptors to androsterone. In contrast to previous reports in which recombinant glycine receptors were inhibited by progesterone, a potentiating effect was revealed by our experiments. At concentrations of 0.1 mM and higher, there were also hints to a channel block-like mechanism. In conclusion, different molecular mechanisms of interaction between neuroactive steroids and GABA as well as glycine receptors could be identified and quantitatively described. Our data clarify the role of steroid compounds in the modulation of inhibitory receptor channel function.
Ziegler
Elke
E
Department of Neurology, Medical University Hannover, 30625 Hanover, Germany. Ziegler.Elke@arcor.de
Bodusch
M
M
Song
Y
Y
Jahn
K
K
Wolfes
H
H
Steinlechner
S
S
Dengler
R
R
Bufler
J
J
Krampfl
K
K
D000738:Androsterone / Q000378:metabolism*; D002460:Cell Line; D005998:Glycine / Q000378:metabolism*; D006801:Humans; D015640:Ion Channel Gating; D008024:Ligands; D008564:Membrane Potentials; D009433:Neural Inhibition; D018408:Patch-Clamp Techniques; D011374:Progesterone / Q000378:metabolism*; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism*; D018009:Receptors, Glycine / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
C546240:GABRA1 protein, human; C495710:GABRB2 protein, human; C546279:GABRG2 protein, human; C114561:GLRB protein, human; D008024:Ligands; D011963:Receptors, GABA-A; D018009:Receptors, Glycine; D011374:Progesterone; D000738:Androsterone; D005998:Glycine
Neuropharmacology. 2001 Sep;41(3):369-76
11522328
Neuroendocrinology. 2006;84(4):244-54
17159334
Trends Pharmacol Sci. 1995 Sep;16(9):295-303
7482994
Neuron. 1990 May;4(5):759-65
2160838
Br J Pharmacol. 1997 Dec;122(8):1707-19
9422818
Brain Res. 1999 May 29;830(1):72-87
10350561
J Clin Endocrinol Metab. 2000 May;85(5):2072-5
10843198
Pain. 2005 Apr;114(3):429-443
15777868
J Clin Endocrinol Metab. 1994 May;78(5):1003-8
8175951
Eur J Neurosci. 2005 Jul;22(1):10-20
16029191
J Biol Chem. 2006 Nov 17;281(46):34918-25
17001074
Recent Prog Horm Res. 1997;52:1-32
9238846
Neuron. 1992 Sep;9(3):491-6
1326295
Prog Neurobiol. 2003 Sep;71(1):67-80
14611869
Annu Rev Physiol. 1997;59:365-93
9074769
Eur J Pharmacol. 2002 Jan 18;435(1):1-8
11790372
Neurology. 1999 Jun 10;52(9):1917-8
10371551
Fertil Steril. 2005 Sep;84(3):701-10
16169406
Ciba Found Symp. 1990;153:3-12; discussion 12-21
1981352
Trends Pharmacol Sci. 2002 Nov;23(11):519-27
12413807
Endocrinology. 1999 Aug;140(8):3843-52
10433246
Growth Horm IGF Res. 2004 Jun;14 Suppl A:S18-33
15135772
Neuroscience. 2006;138(3):821-9
16310966
EMBO J. 1991 Sep;10(9):2401-9
1651228
Neuroscience. 2005;135(2):475-83
16125853
Prog Neurobiol. 1992;38(4):379-95
1349441
J Physiol. 1992 Oct;456:215-45
1338096
J Neurochem. 2006 Jun;97(6):1600-10
16805771
Ann N Y Acad Sci. 2006 Nov;1088:139-52
17192562
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):187-94
17113981
Mol Neurobiol. 1998 Aug;18(1):35-86
9824848
EMBO J. 1988 Dec 1;7(12):3717-26
2850172
Brain Res. 1979 Jul 27;171(1):113-20
223731
Neurology. 2005 Oct 11;65(7):1016-20
16217052
Trends Neurosci. 1991 Oct;14(10):458-61
1722365
Nature. 1994 Feb 17;367(6464):607-14
7509043
Brain Res. 1994 Apr 18;643(1-2):194-203
8032914
Br J Pharmacol. 1988 Aug;94(4):1257-69
2850060
Br J Anaesth. 2004 May;92(5):704-11
15033889
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7394-8
2459705
Mol Pharmacol. 1990 May;37(5):597-602
2338942
Eur J Pharmacol. 1993 Aug 15;246(3):239-46
8223947
Brain Res Dev Brain Res. 1997 Sep 20;102(2):157-65
9352098
AAPS J. 2006 May 26;8(2):E353-61
16796386
J Neurosci. 2002 Mar 1;22(5):1541-9
11880484
Brain Res Brain Res Rev. 2001 Nov;37(1-3):68-80
11744075
Neuroreport. 2000 Sep 11;11(13):3007-10
11006984
Steroids. 1999 Jan-Feb;64(1-2):83-91
10323676
Postepy Hig Med Dosw. 1995;49(3):409-24
8657639
FASEB J. 1992 Mar;6(6):2311-22
1347506
Arch Neurol. 1986 Apr;43(4):347-50
3082313
J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402
9253307
Steroids. 2005 May-Jun;70(5-7):407-17
15862824
Acta Neurol Scand. 1984 Apr;69(4):240-8
6430018
Pflugers Arch. 1981 Aug;391(2):85-100
6270629
Biochem Pharmacol. 1995 Jan 6;49(1):1-16
7840775
Annu Rev Genet. 1985;19:209-52
3909942
Ion Channels. 1996;4:89-113
8744207
Pain. 2000 Oct;88(1):31-39
11098097
Neuron. 2005 Mar 3;45(5):727-39
15748848
Ciba Found Symp. 1990;153:56-71; discussion 71-82
1963400
Epilepsia. 2005 Jun;46(6):819-27
15946323
Eur J Endocrinol. 2001 Dec;145(6):669-79
11720889
Neurosci Lett. 1998 Nov 13;256(3):143-6
9855360
Neuroscience. 2006 Sep 15;141(4):2041-50
16806717
Brain Res. 2004 Mar 12;1000(1-2):8-18
15053947
Science. 1941 Jul 25;94(2430):94
17774030
Eur Biophys J. 2003 Sep;32(6):529-36
14551753